Serum Soluble Vascular Endothelial Growth Factor Receptor 1 as a Potential Biomarker of Hepatopulmonary Syndrome.
Yu-Jie LiXian-Feng WuDan-Dan WangPeng LiHao LiangXiao-Yan HuJia-Qi GanYi-Zhu SunJun-Hong LiJun LiXin ShuAi-Lin SongChun-Yong YangZhi-Yong YangWei-Feng YuLi-Qun YangXiao-Bo WangKarine BelguiseZheng-Yuan XiaBin YiPublished in: Journal of clinical and translational hepatology (2023)
Our results from animal and human studies indicate that sFlt-1 and the sFlt-1/PLGF ratio in serum are potential markers for HPS.